0001140361-12-033917.txt : 20120725
0001140361-12-033917.hdr.sgml : 20120725
20120725152334
ACCESSION NUMBER: 0001140361-12-033917
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120723
FILED AS OF DATE: 20120725
DATE AS OF CHANGE: 20120725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wood Mark
CENTRAL INDEX KEY: 0001401782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 12978832
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2012-07-23
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001401782
Wood Mark
C/O BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO
CA
94949
0
1
0
0
VP, Human Resources
Common Stock
2012-07-23
2012-07-23
4
M
0
813
26.49
A
33177
D
Common Stock
2012-07-23
2012-07-23
4
M
0
83
17.86
A
33260
D
Common Stock
2012-07-23
2012-07-23
4
M
0
937
14.39
A
34197
D
Common Stock
2012-07-23
2012-07-23
4
M
0
833
21.51
A
35030
D
Common Stock
2012-07-23
2012-07-23
4
S
0
2666
39.2473
D
32364
D
Stock Option (right to buy) Common Stock
26.49
2012-07-23
2012-07-23
4
M
0
813
0
D
2011-11-12
2021-05-11
Common Stock
813
122693
D
Stock Option (right to buy) Common Stock
17.86
2012-07-23
2012-07-23
4
M
0
83
0
D
2009-06-17
2018-12-16
Common Stock
83
122610
D
Stock Option (right to buy) Common Stock
14.39
2012-07-23
2012-07-23
4
M
0
937
0
D
2009-11-12
2019-05-11
Common Stock
937
121673
D
Stock Option (right to buy) Common Stock
21.51
2012-07-23
2012-07-23
4
M
0
833
0
D
2010-11-12
2020-05-11
Common Stock
833
120840
D
Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 10, 2011.
The price in Column 4 is a weighted average price. The prices actually received ranged from $39.02 to $39.75. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Original option grant vests 6/48th on November 12, 2011 and 1/48th each on the 12th of each month thereafter.
Original option grant vests 6/48th on June 17, 2009 and 1/48th each on the 17th of each month thereafter.
Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.
Original option grant vests 6/48th on November 12, 2010 and 1/48th each on the 12th of each month thereafter.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2012-07-25